EU electromedical market to slow in 2000:
This article was originally published in Clinica
The European market for electromedical equipment will reach about $3 billion by the end of 1999, predicts COCIR, the European Co-ordination Committee of the Radiological and Electromedical Industries. This represents a 3% increase on last year's performance but growth is expected to slow to about 1% during 2000. The slowdown is largely due to continued cost containment policies in Europe's healthcare sector, says COCIR.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.